Outlook Therapeutics Inc (NASDAQ:OTLK)
| 2.41 Delayed Data As of 5:34pm ET |  +0.15 / +6.64%Today’s Change | 0.58 Today|||52-Week Range 4.26 | +85.38% Year-to-Date |
Latest OTLK News | Press Releases
| Why Outlook Therapeutics Stock Surged Today 5:34pm / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 2.26 |
| Today’s open | 3.01 |
| Day’s range | 2.37 - 3.27 |
| Volume | 2,551,203 |
| Average volume (3 months) | 2,163,784 |
| Market cap | $392.3M |
Data as of 5:34pm ET, 08/03/2021
Growth & Valuation
| Earnings growth (last year) | +66.00% |
| Earnings growth (this year) | +36.17% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | 40.2 |
| Price/Sales | -- |
| Price/Book | 101.71 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MTEMMolecular Templates ... | -0.06 | -0.85% |
| GERNGeron Corp | -0.02 | -2.00% |
| ---- | ||
| SELBSelecta Biosciences ... | +0.16 | +4.52% |
Data as of 5:27pm ET, 08/03/2021
Financials
| Next reporting date | August 19, 2021 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$35.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Iselin, New Jersey |
Forecasts
